Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
Autologous stem cell transplantation (ASCT) is the standard of care for multiple myeloma (MM) and relapsing non-Hodgkin's lymphoma (NHL) patients. Peripheral blood stem cells (PBSC) have become the main source of grafts for ASCT due to several advantages over bone marrow grafts. Poor PBSC mobil...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
Frontiers Media S.A.,
2011-10-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |